 | • レポートコード：MRC2304D091 • 出版社/出版日：Transparency Market Research / 2023年1月9日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、神経血管デバイスの世界市場を分析し、市場実態を明らかにしています。本書は、エグゼクティブサマリー、市場概要、市場背景、市場分析＆予測、デバイス種類別（脳塞栓＆動脈瘤コイリング装置、脳血管形成＆ステント装置、神経血栓除去装置、サポート装置）分析、治療用途別（脳卒中、脳動脈狭窄症、脳動脈瘤、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析などを収録しています。また、Medtronic、Microport Scientific Corporation、Penumbra Inc、Stryker、Johnson & Johnson Services Inc.、Microvention Inc.、Codman Neuroなどの企業情報を掲載しています。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・市場分析＆予測 ・世界の神経血管デバイス市場規模：デバイス種類別 - 脳塞栓＆動脈瘤コイリング装置の市場規模 - 脳血管形成＆ステント装置の市場規模 - 神経血栓除去装置の市場規模 - サポート装置の市場規模 ・世界の神経血管デバイス市場規模：治療用途別 - 脳卒中における市場規模 - 脳動脈狭窄症における市場規模 - 脳動脈瘤における市場規模 - その他治療用途における市場規模 ・世界の神経血管デバイス市場規模：地域別 - 北米の神経血管デバイス市場規模 - ヨーロッパの神経血管デバイス市場規模 - アジア太平洋の神経血管デバイス市場規模 - 中東・アフリカの神経血管デバイス市場規模 - 中南米の神経血管デバイス市場規模 ・市場構造分析 ・競争分析 |
Neurovascular Devices Market – Scope of Report
TMR’s report on the global neurovascular devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurovascular devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurovascular devices market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurovascular devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurovascular devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neurovascular devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurovascular devices market.
The report delves into the competitive landscape of the global neurovascular devices market. Key players operating in the global neurovascular devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurovascular devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market neurovascular devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Bn) & Volume (Units) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Device Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Device Type, 2018-2022
5.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Device Type, 2023-2033
5.3.1. Cerebral Embolization and Aneurysm Coiling Devices
5.3.1.1. Embolic Coils
5.3.1.2. Flow Diversion Devices
5.3.1.3. Liquid Embolic Agents
5.3.2. Cerebral Angioplasty and Stenting Systems
5.3.2.1. Carotid Artery Stents
5.3.2.2. Embolic protection
5.3.3. Neurothrombectomy Devices
5.3.3.1. Clot Retrieval Devices
5.3.3.2. Suction Devices
5.3.3.3. Vascular Snares
5.3.4. Support Devices
5.3.4.1. Micro Catheters
5.3.4.2. Micro Guidewires
5.4. Y-o-Y Growth Trend Analysis By Device Type, 2018-2022
5.5. Absolute $ Opportunity Analysis By Device Type, 2023-2033
6. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutic Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Therapeutic Application, 2018-2022
6.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Therapeutic Application, 2023-2033
6.3.1. Stroke
6.3.1.1. Cerebral Artery Stenosis
6.3.1.2. Cerebral Aneurysm
6.3.1.3. Other Therapeutic Applications
6.3.2. Cerebral Artery Stenosis
6.3.3. Cerebral Aneurysm
6.3.4. Other Therapeutic Applications
6.4. Y-o-Y Growth Trend Analysis By Therapeutic Application, 2018-2022
6.5. Absolute $ Opportunity Analysis By Therapeutic Application, 2023-2033
7. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Region, 2018-2022
7.3. Current Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Region, 2023-2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
8.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
8.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
8.2.1. By Country
8.2.1.1. Value (US$ Bn) & Volume (Units)ed States
8.2.1.2. Canada
8.2.2. By Device Type
8.2.3. By Therapeutic Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Device Type
8.3.3. By Therapeutic Application
8.4. Key Takeaways
9. Latin America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Device Type
9.2.3. By Therapeutic Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Device Type
9.3.3. By Therapeutic Application
9.4. Key Takeaways
10. Europe Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Russia
10.2.1.7. Rest of Europe
10.2.2. By Device Type
10.2.3. By Therapeutic Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device Type
10.3.3. By Therapeutic Application
10.4. Key Takeaways
11. Asia Pacific Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. India
11.2.1.4. South Korea
11.2.1.5. Australia
11.2.1.6. Rest of APAC
11.2.2. By Device Type
11.2.3. By Therapeutic Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device Type
11.3.3. By Therapeutic Application
11.4. Key Takeaways
12. MEA Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. South Africa
12.2.1.2. Saudi Arabia
12.2.1.3. UAE
12.2.1.4. Israel
12.2.1.5. Rest of MEA
12.2.2. By Device Type
12.2.3. By Therapeutic Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device Type
12.3.3. By Therapeutic Application
12.4. Key Takeaways
13. Key Countries Neurovascular Devices Market Analysis
13.1. Value (US$ Bn) & Volume (Units)ed States
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Device Type
13.1.2.2. By Therapeutic Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Device Type
13.2.2.2. By Therapeutic Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Device Type
13.3.2.2. By Therapeutic Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Device Type
13.4.2.2. By Therapeutic Application
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Device Type
13.5.2.2. By Therapeutic Application
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Device Type
13.6.2.2. By Therapeutic Application
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Device Type
13.7.2.2. By Therapeutic Application
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Device Type
13.8.2.2. By Therapeutic Application
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Device Type
13.9.2.2. By Therapeutic Application
13.10. Russia
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Device Type
13.10.2.2. By Therapeutic Application
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Device Type
13.11.2.2. By Therapeutic Application
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Device Type
13.12.2.2. By Therapeutic Application
13.13. India
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Device Type
13.13.2.2. By Therapeutic Application
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Device Type
13.14.2.2. By Therapeutic Application
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Device Type
13.15.2.2. By Therapeutic Application
13.16. South Africa
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Device Type
13.16.2.2. By Therapeutic Application
13.17. Saudi Arabia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Device Type
13.17.2.2. By Therapeutic Application
13.18. UAE
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Device Type
13.18.2.2. By Therapeutic Application
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Device Type
13.19.2.2. By Therapeutic Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Device Type
14.3.3. By Therapeutic Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Medtronic
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. Microport Scientific Corporation
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Penumbra Inc
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Stryker
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Johnson & Johnson Services Inc
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. MicroVention, Inc.
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Integra LifeSciences Corporation
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
